CTT Pharmaceutical Holdings Inc (CTTH PINK) stock market data APIs
$0.0783
-0(-0%)
as of May 1, 2026
Try our APIs with
free plan!
CTT Pharmaceutical Holdings Inc Financial Data Overview
Price chart is built with
Anychart
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Prev. Close
0.0783
Open
0.0776
High
0.0796
Low
0.075
52 wk Range
0.017-0.1
Market Cap
4 655 K
P/E Ratio
0
Shares Outstanding
58 837 K
EPS
0
Beta
0.567
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CTT Pharmaceutical Holdings Inc data using free add-ons & libraries
Get CTT Pharmaceutical Holdings Inc Fundamental Data
CTT Pharmaceutical Holdings Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -120 338
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get CTT Pharmaceutical Holdings Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2025-12-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CTT Pharmaceutical Holdings Inc News
New
CTT Pharmaceutical Holdings CEO Ryan Khouri buys $240 in shares
CTT Pharmaceutical Holdings (CTTH) CEO Ryan Khouri reported purchasing 8,000 shares of company stock on July 8, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shar...
CTT Pharmaceutical Holdings, Inc. Provides Corporate Update
Hamilton, Ontario, July 19, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC:CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery syst...
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces National Patent Applications Worldwide for Orally Administrable Nanonized Opioids, Cannabinoids, Nutraceuticals and Other Pharmaceutical Agents
Includes All Markets in which Aurora Cannabis Currently Operates or Contemplates Future Operations Hamilton, Ontario, Jan. 15, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (“CTT�...
CTT Pharmaceuticals Initiates Legal Action Against Rapid Dose Therapeutics Ltd.
Hamilton, Ontario, Oct. 01, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings Inc. ("CTT") (OTC: CTTH) announced today that it is seeking an injunction to restrain Rapid Dose Therapeutics Ltd. (R...
Get CTT Pharmaceutical Holdings Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
